Pink Sheet is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Ligand Avinza Co-promotion Deal Adds 700 Reps; Goal Is 10% Share By 2008

Executive Summary

Ligand's Avinza co-promotion agreement with Organon adds more than 700 reps to detail the extended-release morphine product
Advertisement

Related Content

Akzo Nobel Pharma “Rough Ride” In 2004 Offset By Partnering, R&D Potential
Akzo Nobel Pharma “Rough Ride” In 2004 Offset By Partnering, R&D Potential
Teva’s Generic Remeron Exclusivity Cut To Five Months By FDA Rules
Teva’s Generic Remeron Exclusivity Cut To Five Months By FDA Rules
Schwarz Pharma To Market Elan Verelan PM In Early 1999
Advertisement
UsernamePublicRestriction

Register

PS041356

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel